Systemic sclerosis refractory disease: From the skin to the heart

被引:35
作者
Almeida, Isabel [1 ,2 ]
Faria, Raquel [1 ]
Vita, Pedro [1 ,2 ]
Vasconcelos, Carlos [1 ]
机构
[1] Ctr Hosp Porto, Hosp Santo Antonio, Unidade Imunol Clin, P-4099001 Oporto, Portugal
[2] Univ Porto, UMIB, ICBAS, P-4100 Oporto, Portugal
关键词
Systemic sclerosis; Refractory autoimmune disease; Refractory scleroderma; PULMONARY ARTERIAL-HYPERTENSION; INTERSTITIAL LUNG-DISEASE; SCLERODERMA RENAL CRISIS; MYCOPHENOLATE-MOFETIL; RAYNAUDS-PHENOMENON; DIFFUSE SCLERODERMA; CONTROLLED-TRIAL; OPEN-LABEL; CYCLOPHOSPHAMIDE; AZATHIOPRINE;
D O I
10.1016/j.autrev.2011.04.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic sclerosis or scleroderma (SSc) is an heterogeneous disease involving the connective tissue and the microvasculature with fibrosis and vascular occlusion. It is difficult to define refractory SSc once it is itself a paradigm of a refractory condition: there is no evidence of when to act to stop the progression to fibrosis and irreversible microvascular damage. There is no definition of refractory disease in SSc and to propose a definition we used mainly the Medsger severity index and the EULAR 2009 treatment recommendations from the skin to the heart through peripheral vascular, musculoskeletal, gastrointestinal, renal, pulmonary hypertension and interstitial lung disease. We used some clinical setting reflecting the different reasoning when there is probable refractory disease and finally we briefly pointed out some available treatment options to refractory disease. With this reflection, we would like to open paths to a broader discussion. (C) 2011 Published by Elsevier B.V.
引用
收藏
页码:693 / 701
页数:9
相关论文
共 81 条
[1]  
Akesson A, 2003, CLIN EXP RHEUMATOL, V21, pS5
[2]  
Allanore Y, 2010, CLIN EXP RHEUMATOL, V28, pS48
[3]   Anti-Neutrophil Antibody Associated Vasculitis in Systemic Sclerosis [J].
Arad, Uri ;
Balbir-Gurman, Alexandra ;
Doenyas-Barak, Keren ;
Amit-Vazina, Mirit ;
Caspi, Dan ;
Elkayam, Ori .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) :223-229
[4]   Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies [J].
Avouac, Jerome ;
Airo, Paulo ;
Meune, Christophe ;
Beretta, Lorenzo ;
Dieude, Philippe ;
Caramaschi, Paola ;
Tiev, Kiet ;
Cappelli, Susanna ;
Diot, Elisabeth ;
Vacca, Alessandra ;
Cracowski, Jean-Luc ;
Sibilia, Jean ;
Kahan, Andre ;
Matucci-Cerinic, Marco ;
Allanore, Yannick .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) :2290-2298
[5]  
Belch JJF, 2000, AM J CLIN NUTR, V71, p352S, DOI 10.1093/ajcn/71.1.352s
[6]   Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition? [J].
Black, C .
RHEUMATOLOGY, 2005, 44 (02) :141-142
[7]  
Bogoch ER, 2005, J RHEUMATOL, V32, P642
[8]   Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity [J].
Caramaschi, P. ;
Canestrini, S. ;
Martinelli, N. ;
Volpe, A. ;
Pieropan, S. ;
Ferrari, M. ;
Bambara, L. M. ;
Carletto, A. ;
Biasi, D. .
RHEUMATOLOGY, 2007, 46 (10) :1566-1569
[9]   The heart in scleroderma [J].
Champion, Hunter C. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2008, 34 (01) :181-+
[10]   MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon A Randomized, Controlled Trial [J].
Chung, Lorinda ;
Shapiro, Lee ;
Fiorentino, David ;
Baron, Murray ;
Shanahan, Joseph ;
Sule, Sangeeta ;
Hsu, Vivien ;
Rothfield, Naomi ;
Steen, Virginia ;
Martin, Richard W. ;
Smith, Edwin ;
Mayes, Maureen ;
Simms, Robert ;
Pope, Janet ;
Kahaleh, Bashar ;
Csuka, M. E. ;
Gruber, Barry ;
Collier, David ;
Sweiss, Nadera ;
Gilbert, Adam ;
Dechow, Frederick J. ;
Gregory, Jeffrey ;
Wigley, Fredrick M. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (03) :870-877